Skip to main content

and
  1. Article

    Open Access

    Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: a nationwide population-based study

    As more patients are treated by haematopoietic stem cell transplantation (HSCT), development of secondary malignancy (SM) becomes an increasingly common issue in long-term survivors.

    S-H Chien, C-J Liu, Y-C Hong, C-J Teng, Y-W Hu, C-C Shen in British Journal of Cancer (2015)

  2. No Access

    Article

    In vivo growth suppression of CT-26 mouse colorectal cancer cells by adenovirus-expressed small hairpin RNA specifically targeting thymosin beta-4 mRNA

    Thymosin beta-4 (Tβ4) is known to be involved in tumorigenesis. Overexpression of this polypeptide has been observed in a wide variety of cancers, including colorectal carcinoma (CRC). Accordingly, Tβ4 has been p...

    T-C Chao, L-C Chan, S-Y Ju, M-C Tang, C-Y Liu, P-M Chen, C-H Tzeng in Cancer Gene Therapy (2014)

  3. Article

    Open Access

    How to predict the outcome in mature T and NK cell lymphoma by currently used prognostic models?

    To select an appropriate prognostic model in the treatment of mature T- and natural killer (NK) -cell lymphoma (peripheral T-cell lymphoma (PTCL) and NK-/T-cell lymphoma (NKTCL)) is crucial. This study investi...

    H-N Lin, C-Y Liu, J-T Pai, F-P Chang, C-F Yang, Y-B Yu, L-T Hsiao in Blood Cancer Journal (2012)

  4. No Access

    Article

    VEGF −460T → C polymorphism and its association with VEGF expression and outcome to FOLFOX-4 treatment in patients with colorectal carcinoma

    The −460T → C polymorphism of vascular endothelial growth factor (VEGF) gene significantly increases its promoter activity. A pilot study was conducted to assess the influence of this polymorphism on clinicopa...

    M-H Chen, C-H Tzeng, P-M Chen, J-K Lin, T-C Lin, W-S Chen in The Pharmacogenomics Journal (2011)